Metacrine: Rises at open in market debut

Metacrine

16/09/2020 16:41

** Shares of drug developer  MTCR.O  rise 7.7% to $14 after
its debut on Nasdaq
    ** Shares open at $14.39 vs. IPO price of $13/shr
    ** Co, on Tuesday, raised $85 mln in its IPO, after pricing
6.54 mln shares at middle of expected range of $12-$14 per share
 urn:newsml:reuters.com:*:nGNX1c3QZn
    ** MTCR develops pipeline therapies to treat liver and
gastrointestinal diseases 
    ** Jefferies, Evercore ISI and RBC Capital Markets were
joint book-running managers for offering

 (Reporting by Madhvi Pokhriyal in Bengaluru)
 ((madhvi.pokhriyal@thomsonreuters.com))